Application of endothelial cell-binding superoxide dismutase (EC-SOD) on screening of the initiation-progress of renal diseases
Application of endothelial cell-binding superoxide dismutase (EC-SOD) on screening of the initiation-progress of renal diseases
批准号:
10672044
负责人:
ADACHI Tetsuo
金额:
$2.11万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
细胞外超氧化物歧化酶(EC-SOD)是一种分泌型蛋白质,是细胞外液中主要的超氧化物歧化酶同工酶。EC-SOD的一个显著特征是它对类肝素物质的亲和力,并且99%以上的这种酶被锚定在血管壁中的硫酸肝素蛋白多糖上。EC-SOD的一小部分存在于循环中,平衡于血浆相和内皮细胞的糖萼之间。我们曾报道血液透析患者血浆EC超氧化物歧化酶水平高于正常人。(1)尿液EC超氧化物歧化酶水平与尿N-乙酰-β-D-氨基葡萄糖苷酶(NAG)排泄量呈显著正相关。EC-SOD似乎不是通过肾小球滤过从血浆中泄漏出来的,而是从肾小管或其周围组织中分泌出来的。尿EC-SOD水平与尿cAMP水平呈显著正相关。CAMP类似物和腺苷环化酶调节剂显著刺激EC…的表达体外培养成纤维细胞系中More-SOD的表达。此外,体内Ellsworth-Howard试验显示,随着尿cAMP水平的升高,尿EC-SOD也随之升高。综上所述,这些观察结果提示,刺激腺苷环化酶-cAMP系统的因子(S)调节EC-超氧化物歧化酶的表达。(2)超氧阴离子和其他氧自由基参与了肾功能衰竭的进展。EC-SOD基因的单碱基替换导致肝素结合区的精氨酸-213(R213G)与甘氨酸的交换,导致该酶与内皮细胞的结合能力降低。维持性血液透析患者EC-SOD基因R213G突变频率明显高于正常人。糖尿病(DM)患者血液透析开始3年后,替换阳性患者的比例呈下降趋势。糖尿病患者中有无R213G的患者存活率差异有统计学意义。提示EC-SOD基因R213G突变可作为判断血液透析患者预后的指标。较少
英文摘要
Extracellular-superoxide dismutase (EC-SOD) is a secretory protein that is the major SOD isozyme in extracellular fluids. A prominent feature of EC-SOD is its affinity to heparin-like substances and more than 99% of this enzyme is anchored to heparan sulfate proteoglycans in the blood vessel walls. The minor parts of EC-SOD is present in the circulation in equilibrium between the plasma phase and the glycocalyx of the endothelium. We have reported that the plasma levels of EC-SOD was higher in hemodialysis patients than in healthy persons.(1) The urinary EC-SOD level was significantly correlated with the urinary excretion of N-acetyl-β-D-glucosaminidase (NAG). EC-SOD appears not to be leaked from the plasma by glomerular filtration, but rather to be secreted from the renal tubule or its surrounding tissues. The urinary EC-SOD level was also significantly correlated with the urinary camp level. camp analogues and adenylate cyclase modulators significantly stimulated the expression of EC … More -SOD in cultured fibroblast cell lines in vitro. Moreover, in vivo Ellsworth-Howard tests, increased urinary EC-SOD accompanied with the elevations of urinary cAMP. Together these observations suggest that factor(s) that stimulate the adenylate cyclase-cAMP system regulate the EC-SOD expression.(2) The superoxide and other oxygen radicals have been implicated in the progress of renal failure. A single base substitution of EC-SOD gene causing exchange of glycine for arginine-213 (R213G) in the heparin-binding domain leads the reduction of the binding capability of this enzyme to endothelial cells. The frequency of the R213G mutation of EC-SOD were higher in hemodialysis patients than in healthy persons. Percentage of substitution positive patients was declining 3 years after the start of hemodialysis in patients with diabetes mellitus (DM). There were significant differences in the survival rate between patients with and without R213G in DM. These results suggest that the R213G mutation of EC-SOD could be a prognostic marker of dialysis patients. Less
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Hirokazu Hara, Noriyasu Mitani, Tetsuo Adachi: "Inhibitory effect of nitric oxide on the induction of Cytochrome P450 3A4 mRNA by 1,25 dihydroxy vitamine D3 in Caco-2 cells"Free Radical Res.. (in press). (2000)
Hirokazu Hara、Noriyasu Mitani、Tetsuo Adachi:“一氧化氮对 Caco-2 细胞中 1,25 二羟基维生素 D3 诱导细胞色素 P450 3A4 mRNA 的抑制作用”自由基研究(正在出版)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
前畑英介ら: "糖尿症性合併症 Vol.11" 糖尿病性合併症研究会(メディカルジャーナル社), 6 (1998)
Eisuke Maehata 等:“糖尿病并发症第 11 卷”糖尿病并发症研究组(医学杂志),6 (1998)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T. Adachi, N. Yamazaki, et al.: "Changes in the heparin affinity of extracellular-superoxde dismutase in patients with coronary artery atherosclerosis"Biol. Pharm. Bull.. 21. 1090-1093 (1998)
T. Adachi、N. Yamazaki 等人:“冠状动脉粥样硬化患者细胞外超氧化物歧化酶的肝素亲和力的变化”Biol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
T. Adachi, H. Yamada, et al.: "Increase of urinary extracellualr-superoxide dismutase level correlated with cyclic adenosine monophosphate"FEBSL Letters. 458. 370-374 (1999)
T. Adachi、H. Yamada 等人:“尿细胞外超氧化物歧化酶水平的增加与环磷酸腺苷相关”FEBSL Letters。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
前畑英介、足立哲夫 ら: "糖尿病性合併症 Vol.11"糖尿病性合併症研究会(メディカルジャーナル社). 6 (1998)
Eisuke Maehata、Tetsuo Adachi 等:“糖尿病并发症第 11 卷”糖尿病并发症研究小组(医学杂志)6 (1998)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 27 条
Contribution of impairment of redox-regulation in development of Intraretinal microvascular abnormalities
-
批准号:21590169
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:ADACHI Tetsuo
-
依托单位:
Regulation of anti-arteriosclerotic activity between anti-oxidative enzyme and adipocytokines
-
批准号:18590146
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.62万
-
财政年份:2006
-
负责人:ADACHI Tetsuo
-
依托单位:
The medicine that functions to maintain the redox state might to the pathological conditions of insulin resistance
-
批准号:15590062
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:2003
-
负责人:ADACHI Tetsuo
-
依托单位:
Dysfunction of protection enzymes of vascular endothelial cell surface results in the pathogenesis of cardiovascular disease
-
批准号:12672113
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:2000
-
负责人:ADACHI Tetsuo
-
依托单位:
Contribution of glutathione to multidrug resistance and the its regulation with active oxygen modulators
-
批准号:08672521
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$0.77万
-
财政年份:1996
-
负责人:ADACHI Tetsuo
-
依托单位:
国内基金
海外基金
登录
查看更多内容
3 ′,5 ′-cAMP 信号介导鲍曼不动杆菌噬菌体防御功能的分子机制研究
-
批准号:ZCLQN26C0101
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:崔彬彬
-
依托单位:
Neuromedin B/cAMP 信号轴通过增强 mPFCCaMKII 神经元突触可塑性介导银屑病共病焦虑障碍的机制研究
-
批准号:ZCLMS26H0902
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:华书山
-
依托单位:
基于cAMP/PKA/TRPV1信号通路介导外泌体研究续筋接骨液干预肩袖损伤的作用机制
-
批准号:2026JJ82390
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张萍
-
依托单位:
基于cAMP-CAL-CFTR信号轴探讨滋阴疗法干预慢传输型便秘作用机制研究
-
批准号:JCZRLH202600945
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于“神-魂-精”稳态平衡理论研究古汉养生精调控 cAMP/PKA/CREB 信号通路改善失眠的机制
-
批准号:2026JJ81600
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:胡文孝
-
依托单位:
溴莫尼定通过cAMP/PKA/CREB轴调控MMP-2表达延缓近视眼轴增长的机制研究
-
批准号:2026JJ70126
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:向爱群
-
依托单位:
甜叶悬钩子苷激活cAMP-PKA-mTOR通路增强海马突触可塑性改善大鼠难治性抑郁
-
批准号:2026JJ80382
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:龚凤翔
-
依托单位:
基于甜味受体T1R2/T1R3-cAMP/PKA信号通路“滋味-效味”整合的湖湘蜜蒸玉竹“滋阴润燥”增效机制研究
-
批准号:2026JJ82567
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王硕辉
-
依托单位:
C6orf15通过调控cAMP/PPAR信号通路促进肺腺癌增殖转移的分子机制研究
-
批准号:2026JJ81286
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:莫靓
-
依托单位:
ADM激活cAMP-PKA磷酸化CREB介导巨噬细
胞极化负向调控宿主抗结核免疫机制研
究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:朱家楼
-
依托单位: